MYO1E: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. In dendritic cells, may control the movement of class II-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via ARL14EP and ARL14. Defects in MYO1E are the cause of focal segmental glomerulosclerosis type 6 (FSGS6). A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. FSGS6 is a childhood-onset disorder resulting in nephrotic syndrome, which includes massive proteinuria, hypoalbuminemia, hyperlipidemia, and edema.
Protein type: Motor; Motility/polarity/chemotaxis; Actin-binding
Chromosomal Location of Human Ortholog: 15q21-q22
Cellular Component: cytoskeleton; adherens junction; cytoplasm; intercellular junction; clathrin-coated endocytic vesicle; myosin complex; actin cytoskeleton
Molecular Function: calmodulin binding; microfilament motor activity; actin filament binding; protein binding; motor activity; ATPase activity, coupled; phosphoinositide binding; ATP binding
Biological Process: nitrogen compound metabolic process; actin filament-based movement; post-embryonic hemopoiesis; in utero embryonic development; glomerular filtration; glomerular basement membrane development; platelet-derived growth factor receptor signaling pathway; endocytosis; vasculogenesis
Disease: Focal Segmental Glomerulosclerosis 6
Show more